2 completed, 1 terminated. 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Dextromethorphan 30 mg: new trials by email Literature Review of Dextromethorphan 30 mg trials Research Report on Dextromethorphan 30 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis Ustekinumab IV Infusion, Ustekinumab SC Injection, Midazolam 2 mg - Crohn Disease, Ulcerative Colitis | Phase 1 | Terminated | Janssen Research & Development, LLC | 28 | 2018-02-02 | 2025-08-21 |
| A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects JNJ-54175446 150 mg, JNJ-54175446 600 mg, Midazolam 2 mg - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 16 | 2017-03-14 | 2017-06-08 |
| Add-on Dextromethorphan in Bipolar Disorders Valproate, Dextromethorphan 60 mg per day, Placebo - Bipolar Disorder | Phase 3 | Completed | National Cheng-Kung University Hospital | 300 | 2007-06-01 | 2013-09-17 |
Bipolar Disorder (1) · Colitis, Ulcerative (1) · Crohn Disease (1)
Janssen Research & Development, LLC (2) · National Cheng-Kung University Hospital (1)
Belgium (2) · Germany (1) · Taiwan (1) · United Kingdom (1) · United States (1)
Ru-Band Lu, MD (1)
2016 (1), 2017 (1)